Experience

Davis Polk advised the placing agents for the top-up placement of up to 97,000,000 shares in Innovent Biologics, Inc. for a total consideration of approximately HK$2.4 billion. Davis Polk…

Davis Polk is advising China Yongda Automobiles Services Holdings Limited in connection with its proposed acquisition of the entire issued shares of Inchcape Asia Pacific Limited from a…

Davis Polk advised Tencent Holdings Limited in connection with its purchase of 96,820,000 ordinary shares of Weimob Inc. for an aggregate purchase price of HK$353 million. Before the…

Davis Polk advised Tencent Holdings Limited in connection with its subscription of 1,036,766,038 ordinary shares of China Youzan Limited for an aggregate subscription price of HK$550…

Davis Polk is advising Warburg Pincus and Baring Asia as substantial selling shareholders participating in the partial offer by Xinjiang Xintai Natural Gas Co., Ltd. to acquire a maximum of…

Davis Polk is advising Citigroup Global Markets Asia Limited as independent financial adviser to the independent board committee of Orient Overseas (International) Limited (“OOIL”) on the…

Davis Polk is advising Razer Inc. as to Hong Kong law in relation to its acquisition of MOL Global, Inc. from its other shareholders at a consideration of approximately $61 million. Razer…

Davis Polk is advising Red Star Macalline Group Corporation Ltd. on its HK$4.6 billion (approximately $590 million) proposed voluntary conditional cash offer to repurchase 388,917,038 H…

Davis Polk is advising iRena Group Co., Ltd. in connection with its proposed subscription of shares in Ourgame International Holdings Limited. Pursuant to the terms of the share purchase…

Davis Polk is advising Morgan Stanley Asia Limited as one of the joint financial advisers to China National Building Material Company Limited (“CNBM”) on its proposed merger by absorption…